Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720

BACKGROUND: The most commonly used biomarkers to predict the response of breast cancer patients to therapy are the oestrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2). Patients positive for these biomarkers are eligible for specific therapies suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldacchino, Shawn, Saliba, Christian, Petroni, Vanessa, Fenech, Anthony G, Borg, Nigel, Grech, Godfrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913630/
https://www.ncbi.nlm.nih.gov/pubmed/24460909
http://dx.doi.org/10.1186/1878-5085-5-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913630/
https://www.ncbi.nlm.nih.gov/pubmed/24460909
http://dx.doi.org/10.1186/1878-5085-5-3

Ejemplares similares